Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Scott

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Nature Communications|November 4, 2018
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapiesCarman K M Ip, Patrick K S Ng, Kang Jin Jeong, et al.
Cancer Cell|May 1, 2018
A-to-I RNA Editing Contributes to Proteomic Diversity in CancerXinxin Peng, Xiaoyan Xu, Yumeng Wang, et al.
Plos One|June 4, 2010
Integrative genome comparison of primary and metastatic melanomasOmar Kabbarah, Cristina Nogueira, Bin Feng, et al.
Genome Research|April 16, 2017
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersYumeng Wang, Xiaoyan Xu, Shuangxing Yu, et al.
American Journal of Human Genetics|May 7, 2016
Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome SequencingLixing Yang, Mi-Sook Lee, Hengyu Lu, et al.
Cancer Research|May 18, 2017
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerHengyu Lu, Nicole Villafane, Turgut Dogruluk, et al.
Nature|June 26, 2009
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancerKenneth L Scott, Omar Kabbarah, Mei-Chih Liang, et al.
The Journal of Clinical Investigation|August 16, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.
The Journal of Clinical Investigation|January 12, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.
Molecular Cell|November 27, 2010
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanomaCarmit Levy, Mehdi Khaled, Dimitrios Iliopoulos, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Nature Communications|November 4, 2018
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapiesCarman K M Ip, Patrick K S Ng, Kang Jin Jeong, et al.
Cancer Cell|May 1, 2018
A-to-I RNA Editing Contributes to Proteomic Diversity in CancerXinxin Peng, Xiaoyan Xu, Yumeng Wang, et al.
Plos One|June 4, 2010
Integrative genome comparison of primary and metastatic melanomasOmar Kabbarah, Cristina Nogueira, Bin Feng, et al.
Genome Research|April 16, 2017
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancersYumeng Wang, Xiaoyan Xu, Shuangxing Yu, et al.
American Journal of Human Genetics|May 7, 2016
Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome SequencingLixing Yang, Mi-Sook Lee, Hengyu Lu, et al.
Cancer Research|May 18, 2017
Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerHengyu Lu, Nicole Villafane, Turgut Dogruluk, et al.
Nature|June 26, 2009
GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancerKenneth L Scott, Omar Kabbarah, Mei-Chih Liang, et al.
The Journal of Clinical Investigation|August 16, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.
The Journal of Clinical Investigation|January 12, 2018
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA networkXiaochao Tan, Priyam Banerjee, Xin Liu, et al.
Molecular Cell|November 27, 2010
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanomaCarmit Levy, Mehdi Khaled, Dimitrios Iliopoulos, et al.
Pageof 6